Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thrombin | 8 | 2016 | 593 | 1.950 |
Why?
|
| Polysaccharides | 13 | 2024 | 1016 | 1.230 |
Why?
|
| Glycomics | 4 | 2020 | 109 | 1.130 |
Why?
|
| Lignin | 3 | 2016 | 19 | 1.080 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 3 | 2016 | 144 | 1.050 |
Why?
|
| Microarray Analysis | 5 | 2024 | 747 | 0.970 |
Why?
|
| Microwaves | 1 | 2024 | 185 | 0.830 |
Why?
|
| Glycoproteins | 4 | 2024 | 2208 | 0.740 |
Why?
|
| Tyrosine | 2 | 2023 | 1438 | 0.660 |
Why?
|
| Glycopeptides | 1 | 2020 | 220 | 0.640 |
Why?
|
| Antithrombins | 3 | 2015 | 313 | 0.550 |
Why?
|
| Glycosylation | 8 | 2024 | 1096 | 0.540 |
Why?
|
| Anticoagulants | 4 | 2016 | 4897 | 0.520 |
Why?
|
| Software | 2 | 2020 | 4419 | 0.510 |
Why?
|
| Data Mining | 1 | 2019 | 553 | 0.470 |
Why?
|
| Platelet Aggregation | 2 | 2016 | 805 | 0.460 |
Why?
|
| Drug Design | 4 | 2013 | 1061 | 0.410 |
Why?
|
| Blood Coagulation | 4 | 2016 | 1157 | 0.410 |
Why?
|
| Carrier Proteins | 1 | 2024 | 4938 | 0.360 |
Why?
|
| Sulfates | 3 | 2016 | 379 | 0.330 |
Why?
|
| Lectins, C-Type | 2 | 2022 | 587 | 0.310 |
Why?
|
| Allosteric Regulation | 6 | 2016 | 426 | 0.310 |
Why?
|
| Thromboembolism | 1 | 2013 | 1017 | 0.280 |
Why?
|
| Heparin | 3 | 2016 | 1652 | 0.230 |
Why?
|
| Factor XIa | 2 | 2014 | 9 | 0.230 |
Why?
|
| Trichuris | 1 | 2024 | 32 | 0.230 |
Why?
|
| Benzofurans | 3 | 2014 | 142 | 0.230 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2020 | 1544 | 0.220 |
Why?
|
| Phosphorylcholine | 1 | 2024 | 153 | 0.220 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2016 | 3201 | 0.210 |
Why?
|
| Antibodies | 2 | 2020 | 2421 | 0.200 |
Why?
|
| Protein Binding | 6 | 2023 | 9335 | 0.200 |
Why?
|
| Lectins | 1 | 2024 | 484 | 0.200 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2013 | 179 | 0.190 |
Why?
|
| Mannose-Binding Lectins | 1 | 2021 | 96 | 0.190 |
Why?
|
| Allosteric Site | 3 | 2016 | 103 | 0.180 |
Why?
|
| Protease Inhibitors | 2 | 2016 | 755 | 0.180 |
Why?
|
| Galectin 3 | 1 | 2022 | 240 | 0.180 |
Why?
|
| Hydrolysis | 3 | 2016 | 665 | 0.170 |
Why?
|
| Fluorescence Polarization | 1 | 2020 | 140 | 0.170 |
Why?
|
| Glycosyltransferases | 1 | 2020 | 118 | 0.170 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 83 | 0.170 |
Why?
|
| Serum | 1 | 2020 | 211 | 0.160 |
Why?
|
| Oligosaccharides | 1 | 2021 | 405 | 0.160 |
Why?
|
| Peptide Library | 1 | 2020 | 347 | 0.160 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2019 | 173 | 0.160 |
Why?
|
| Propylamines | 1 | 2019 | 161 | 0.160 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2020 | 508 | 0.160 |
Why?
|
| Carbohydrates | 1 | 2020 | 388 | 0.160 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2016 | 27 | 0.140 |
Why?
|
| Fluorescence | 1 | 2019 | 751 | 0.140 |
Why?
|
| Binding Sites | 5 | 2020 | 6048 | 0.140 |
Why?
|
| Molecular Mimicry | 2 | 2014 | 200 | 0.140 |
Why?
|
| Thrombelastography | 2 | 2016 | 183 | 0.130 |
Why?
|
| Bleeding Time | 1 | 2016 | 84 | 0.130 |
Why?
|
| Kinetics | 5 | 2015 | 6377 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2024 | 1974 | 0.130 |
Why?
|
| Coumarins | 1 | 2016 | 119 | 0.130 |
Why?
|
| Glycosaminoglycans | 2 | 2016 | 605 | 0.130 |
Why?
|
| Catalytic Domain | 2 | 2016 | 706 | 0.130 |
Why?
|
| Thermodynamics | 2 | 2014 | 599 | 0.130 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 150 | 0.120 |
Why?
|
| Propionates | 1 | 2015 | 182 | 0.120 |
Why?
|
| Synapses | 1 | 2024 | 1757 | 0.120 |
Why?
|
| Antigens | 1 | 2020 | 1447 | 0.120 |
Why?
|
| Blood Coagulation Tests | 1 | 2016 | 270 | 0.120 |
Why?
|
| Workflow | 1 | 2019 | 852 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2016 | 3969 | 0.120 |
Why?
|
| Static Electricity | 1 | 2014 | 261 | 0.110 |
Why?
|
| Prodrugs | 1 | 2015 | 259 | 0.110 |
Why?
|
| Enoxaparin | 1 | 2016 | 397 | 0.110 |
Why?
|
| Platelet-Rich Plasma | 1 | 2016 | 179 | 0.110 |
Why?
|
| Structure-Activity Relationship | 3 | 2013 | 3084 | 0.110 |
Why?
|
| Sulfuric Acid Esters | 1 | 2013 | 31 | 0.110 |
Why?
|
| Hemostasis | 1 | 2016 | 468 | 0.110 |
Why?
|
| Documentation | 1 | 2019 | 893 | 0.110 |
Why?
|
| Antirheumatic Agents | 1 | 2023 | 1374 | 0.110 |
Why?
|
| Binding, Competitive | 1 | 2014 | 1142 | 0.100 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2013 | 276 | 0.100 |
Why?
|
| Patents as Topic | 1 | 2013 | 112 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 3707 | 0.100 |
Why?
|
| Platelet Activation | 1 | 2016 | 660 | 0.100 |
Why?
|
| Sodium Chloride | 1 | 2014 | 591 | 0.100 |
Why?
|
| Animals | 12 | 2024 | 167963 | 0.100 |
Why?
|
| Tetrahydroisoquinolines | 1 | 2012 | 81 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2825 | 0.100 |
Why?
|
| Legislation, Drug | 1 | 2013 | 214 | 0.100 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 978 | 0.090 |
Why?
|
| Sucrose | 1 | 2011 | 156 | 0.090 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 1693 | 0.090 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2016 | 1189 | 0.090 |
Why?
|
| Aniline Compounds | 1 | 2015 | 1069 | 0.090 |
Why?
|
| Hemoglobins | 1 | 2015 | 1521 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 734 | 0.080 |
Why?
|
| Protein Kinase C | 1 | 2014 | 1199 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2013 | 1895 | 0.080 |
Why?
|
| Glucosides | 1 | 2013 | 533 | 0.080 |
Why?
|
| Internet | 1 | 2020 | 3078 | 0.070 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 1993 | 0.070 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 3763 | 0.070 |
Why?
|
| Mice | 5 | 2024 | 81208 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2014 | 2192 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2015 | 2141 | 0.070 |
Why?
|
| Fibrinolytic Agents | 1 | 2016 | 2167 | 0.070 |
Why?
|
| Heparitin Sulfate | 2 | 2016 | 224 | 0.060 |
Why?
|
| Sialyltransferases | 1 | 2024 | 81 | 0.060 |
Why?
|
| Biotinylation | 1 | 2024 | 184 | 0.060 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 6538 | 0.060 |
Why?
|
| Risk | 1 | 2016 | 9631 | 0.060 |
Why?
|
| Hemorrhage | 1 | 2016 | 3600 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 2 | 2024 | 22023 | 0.050 |
Why?
|
| Humans | 20 | 2024 | 760621 | 0.050 |
Why?
|
| Factor Xa | 2 | 2015 | 168 | 0.050 |
Why?
|
| 4-1BB Ligand | 1 | 2022 | 29 | 0.050 |
Why?
|
| Mannose | 1 | 2022 | 121 | 0.050 |
Why?
|
| Italy | 1 | 2024 | 841 | 0.050 |
Why?
|
| Computer Simulation | 1 | 2016 | 6218 | 0.050 |
Why?
|
| Carbohydrate Sequence | 2 | 2013 | 410 | 0.050 |
Why?
|
| Thrombosis | 1 | 2016 | 3052 | 0.050 |
Why?
|
| Models, Molecular | 3 | 2021 | 5434 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2012 | 465 | 0.050 |
Why?
|
| Galectins | 1 | 2023 | 282 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2022 | 585 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2019 | 206 | 0.040 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2019 | 158 | 0.040 |
Why?
|
| Immune System | 1 | 2024 | 798 | 0.040 |
Why?
|
| ABO Blood-Group System | 1 | 2020 | 369 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2019 | 1316 | 0.040 |
Why?
|
| Brain | 1 | 2024 | 26951 | 0.040 |
Why?
|
| Chickens | 1 | 2019 | 860 | 0.040 |
Why?
|
| Heparin Lyase | 1 | 2016 | 37 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13262 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 604 | 0.030 |
Why?
|
| Polymerization | 1 | 2016 | 157 | 0.030 |
Why?
|
| Receptors, Virus | 1 | 2019 | 639 | 0.030 |
Why?
|
| Cattle | 2 | 2012 | 3847 | 0.030 |
Why?
|
| Influenza A virus | 1 | 2019 | 457 | 0.030 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2023 | 1827 | 0.030 |
Why?
|
| Biotransformation | 1 | 2015 | 166 | 0.030 |
Why?
|
| Heparin Cofactor II | 1 | 2015 | 3 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 2019 | 980 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1529 | 0.030 |
Why?
|
| Ligands | 1 | 2021 | 3276 | 0.030 |
Why?
|
| Swine | 1 | 2024 | 5899 | 0.030 |
Why?
|
| Blood Coagulation Factors | 1 | 2016 | 365 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2536 | 0.030 |
Why?
|
| Epitopes | 1 | 2019 | 2503 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2022 | 4264 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3215 | 0.030 |
Why?
|
| Digestion | 1 | 2012 | 53 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2023 | 4090 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2019 | 766 | 0.020 |
Why?
|
| Carboxylic Acids | 1 | 2012 | 90 | 0.020 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2013 | 267 | 0.020 |
Why?
|
| Dimerization | 1 | 2013 | 891 | 0.020 |
Why?
|
| Ultracentrifugation | 1 | 2011 | 183 | 0.020 |
Why?
|
| Prothrombin Time | 1 | 2011 | 116 | 0.020 |
Why?
|
| Partial Thromboplastin Time | 1 | 2011 | 205 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2019 | 2415 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3539 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 29932 | 0.020 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2011 | 345 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 17624 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1792 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2011 | 687 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2013 | 987 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2020 | 4541 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2019 | 8313 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2019 | 1528 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2013 | 3602 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2011 | 1982 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2014 | 1057 | 0.020 |
Why?
|
| Proteins | 1 | 2020 | 6029 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2020 | 8035 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2013 | 3765 | 0.010 |
Why?
|
| Algorithms | 1 | 2015 | 13981 | 0.010 |
Why?
|
| Young Adult | 1 | 2020 | 58741 | 0.010 |
Why?
|
| Male | 2 | 2020 | 359744 | 0.010 |
Why?
|
| Female | 2 | 2020 | 391270 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 220352 | 0.000 |
Why?
|
| Adult | 1 | 2020 | 219994 | 0.000 |
Why?
|
Concepts
(181)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(7)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_